Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies.
about
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and LomustineSecretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death.Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma.Microenvironmental stiffness enhances glioma cell proliferation by stimulating epidermal growth factor receptor signaling.Cancer therapy using nanoformulated substances: scientific, regulatory and financial aspects.Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interactionFungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary aminesStandardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.Isatin derivatives with activity against apoptosis-resistant cancer cells.Method for lipidomic analysis: p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cellsAligned Nanotopography Promotes a Migratory State in Glioblastoma Multiforme Tumor Cells.Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migrationReceptor-Mediated Drug Delivery Systems Targeting to GliomaTowards developing biomarkers for glioblastoma multiforme: a proteomics view.Engineering strategies to mimic the glioblastoma microenvironment.Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.Expression signatures of DNA repair genes correlate with survival prognosis of astrocytoma patients.From glioblastoma to endothelial cells through extracellular vesicles: messages for angiogenesis.On glioblastoma and the search for a cure: where do we stand?Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.A Zebrafish Live Imaging Model Reveals Differential Responses of Microglia Toward Glioblastoma Cells In Vivo.Irradiation of primary human gliomas triggers dynamic and aggressive survival responses involving microvesicle signaling.MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1.Peptide-like Polymers Exerting Effective Glioma-Targeted siRNA Delivery and Release for Therapeutic Application.The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.Nuclear Protein C23 on the Cell Surface Plays an Important Role in Activation of CXCR4 Signaling in Glioblastoma.A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces.Cell surface protein C23 affects EGF-EGFR induced activation of ERK and PI3K-AKT pathways.Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and TreatmentBioinspired Hydrogels to Engineer Cancer Microenvironments.5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cellsA Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma.Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.Anti-cancer capacity of plasma-treated PBS: effect of chemical composition on cancer cell cytotoxicity.Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells.Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma.
P2860
Q33755077-65F2C068-3A48-4FDD-BB81-E35733667BF3Q35024449-2054C8E3-7512-47A1-858A-4E4537F12677Q35162299-2A3D4084-8674-4055-B9FA-CB656D99FE1CQ35202307-D7981FD0-4E45-4CAF-B98F-D8497B6D08F1Q35786517-374E7096-6C97-499B-B2D7-82140C08532DQ35917464-16847F36-D0A9-4FF3-98D1-40AA727D0C5FQ36119458-219DBEAE-8008-40D1-A7B3-6DE7F4C250C0Q36198988-B18D2B81-F802-4ECF-9A2A-FD1B5EFC1B14Q36627739-330348CD-B472-4678-B96D-7DAFA739C280Q36642961-C7C33074-3697-47C0-8228-8A5B6026CF12Q36852844-5582A2AD-3B83-41E8-8AE2-F7701486DF8DQ36910540-36199FC7-473B-477C-A6AB-4D589E99F69FQ37225334-25974805-C800-4E2B-9D34-AEC49A0BC0A9Q37474338-2A3BEDDC-F1B3-4B1A-9420-0FD68A637E98Q37636271-FF72682C-AC21-45E6-99F8-4E3988E0305DQ38239173-8B8F1B0E-5A49-44D5-ADDF-22F81FF0DC4DQ38244936-D2778616-BAEA-48A5-9560-F1BD120C5A2BQ38245925-9E3BE047-AE41-4383-AE5A-77829CCFDE69Q38708860-36B19C03-9C01-4091-BF7C-DFD4795F4F82Q38736928-8D6C16B8-2789-4B77-A781-7F1C67017BCDQ38756293-6344B8BC-3F08-4E6F-8BBC-30D55D14E2AAQ38761444-8293E908-519E-4924-A374-3D40486070DDQ38776367-2690BBC5-7FA6-4CC2-92D4-6BF804890861Q38806032-C314B44A-25C9-4430-A915-6D12D9AD2062Q38817114-7F3962EB-355D-408C-85DA-9B8EE3A3A31FQ38824154-6F4A2593-FECB-4452-8400-3EF0B2AC30CCQ38848206-DDA78735-33D6-4DF6-BBFB-00A2DAEF96D4Q38856091-4EEB4507-4EEB-421C-8763-A99440560160Q38908815-7E4A56B8-ECE8-40F3-8DDB-990BB279A726Q38943023-6E0C9DCF-D139-41F6-B64E-E727EA6C115DQ38973205-83DB36CA-9AC9-4ADE-B3B7-3652E2F638C1Q38976208-E31C4E64-5145-48AC-87BC-C6B462DBAF77Q39152200-672593E9-0C5A-40C0-9C5D-513CA250091BQ39386471-48893882-1CC1-47F6-BC33-0295DC4B2FADQ41744145-64A8D147-CE04-4587-A949-B254BD609EE2Q42113451-9ACB3CB7-71AF-4F06-9685-60007C507696Q43640727-ABF1FA41-B15C-4CD0-974C-BBBF38ED342FQ46252406-2BE665F5-674C-487F-84B2-DFF75DC763C7Q47114557-FD97CC37-82DE-4B81-9B06-DBF444D51A6AQ47164243-477E0CBB-ACB3-4516-9613-F10D6C695EC4
P2860
Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Glioblastoma, a brief review o ...... novel therapeutic strategies.
@en
type
label
Glioblastoma, a brief review o ...... novel therapeutic strategies.
@en
prefLabel
Glioblastoma, a brief review o ...... novel therapeutic strategies.
@en
P2093
P2860
P1476
Glioblastoma, a brief review o ...... novel therapeutic strategies.
@en
P2093
Amparo Wolf
Gelareh Zadeh
James T Rutka
Kelly E Burrell
Sameer Agnihotri
Sharzhad Jalali
P2860
P2888
P356
10.1007/S00005-012-0203-0
P577
2012-12-07T00:00:00Z
P6179
1015480273